MEDTEQ+
VC Fund
Montreal, Canada
MEDTEQ+ is a non-profit organization for industrial research and innovation in medical technology. The organization accelerates the development of innovative technological solutions to improve patients’ health and quality of life by mobilizing Canadian talents. They bringing together the key players in healthcare and innovation allows them andtheir partners, to offer Canadians access to novel solutions.MEDTEQ’s mission is, through collaborative, industry-led projects, to accelerate innovation and position, on a global scale, products and services developed by the Canadian medical technologies industry.
- Total investments:
- 36
- Last investment:
- Lead investor:
- 53%
- Fund size:
- $11M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries MEDTEQ+ invests in
Stages MEDTEQ+ invests in
Countries MEDTEQ+ invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.5M–$4M
- Series A
- $3M–$20M
Investment Focus
Industry
- Health Care 22 (61%)
- Medical Device 13 (36%)
- Biotechnology 6 (17%)
- Medical 5 (14%)
- Artificial Intelligence 5 (14%)
Stage
- Seed 14 (39%)
- Series A 4 (11%)
- Venture - Series Unknown 4 (11%)
- Grant 3 (8%)
- Pre-Seed 3 (8%)
Country
- Canada 26 (72%)
- United States 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Diane Côté
President & CEO
|
President & CEO | Total investments: 1 | Find email | |
|
Jacques Milette
Président sortant du CA, MEDTEQ+
|
Président sortant du CA, MEDTEQ+ | Total investments: 3 | Find email | |
Meryeme Lahmami
Investment manager
|
Investment manager | Total investments: 0 | Find email | |
Robert Ritlop
Director of Investments
|
Director of Investments | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| AI4Eyes focuses on leveraging artificial intelligence to improve the diagnosis and treatment of dry eye disease. The company provides tools and solutions that assist healthcare professionals in identifying and managing this condition more effectively. By utilizing machine learning algorithms, AI4Eyes aims to enhance clinical decision-making andpatient outcomes in ophthalmology. The company addresses the complexity of dry eye disease and the challenges faced by doctors in staying updated with the latest practices. | $492.4K / Grant / Jul 07, 2026 | ||
| At NURA Medical, our mission is to improve pediatric patient care and clinical efficiency in emergency situations. Our IV Assistant facilitates medication preparation, ensuring children receive the right medication dosage every time. | $73K / Grant / Jul 18, 2024 | ||
| Swiftsure Innovations provides registered nurses with the tools required to improve patient outcomes.It develops a medical device that enhances oral care for patients on life support with the aim of decreasing the incidence of ventilator-acquired pneumonia, length of mechanical ventilation, and length of hospital stay.Creative Destruction Labssupports the company. | $1.7M / Seed / May 18, 2023 | ||
| Eli empowers women to understand their body and the transitions it goes through every day, and across life. We develop a device that uses saliva to capture hormone fluctuations at home, and an app that gives women the information they want to own their health decisions. | $3.6M / Seed / Apr 04, 2023 | ||
| Every hospital in the world is faced with a major challenge - the rising cost of heathcare - we want to do something about it. Arbutus Medical’s purpose is to develop a portfolio of “frugal innovation” devices that save costs for hospitals and improve access to orthopedic surgery for 5 million patients by 2030. Arbutus Medical's flagshipproduct is a radically affordable orthopaedic power tool system that is used in North American Trauma Centers, veterinary hospitals, military deployments, NGO missions, and hospitals in over 30 low- and middle-income countries worldwide. | $2.3M / Seed / Feb 13, 2023 | ||
| LUCID curates and creates personalized therapeutic music using biometrics, psychometrics, and AI to improve mental health and wellness. | $2.3M / Seed / Aug 12, 2022 | ||
| LUCID curates and creates personalized therapeutic music using biometrics, psychometrics, and AI to improve mental health and wellness. | $2.5M / Pre-Seed / Aug 12, 2022 | ||
| HALEO’s mission is to improve human health and performance by increasing access to high quality care for poor sleep. Our specialty clinic is accessible through our mobile app, providing professional and digital SaaS solutions that are clinically proven to improve sleep and mood. Our services help organizations reduce costs related to productivitylosses, accidents, burnout and disability by helping their employees sleep better. | $4M / Seed / Jul 05, 2022 | ||
| Ditch Labs is a digital health company pioneering substance addiction treatment by combining AI-driven behavioural therapy with revolutionary drug delivery devices. Using a novel digital therapeutic approach, Ditch is aiming to solve the world’s leading cause of preventable death, starting with nicotine addiction. | $350K / Seed / Feb 14, 2022 | ||
| Sonic Incytes is a medical device start-up company developing quantitative ultrasound for point-of-care diagnostic and procedure guidance. our mission to enable routine assessment and management of liver health, with diagnostic accuracy you can count on. | $7.3M / Series A / Dec 07, 2021 | ||
| See all 36 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does MEDTEQ+ invest in?
MEDTEQ+ invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Seed and Series A stage. Most of the 36 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does MEDTEQ+ invest in?
MEDTEQ+ typically joins rounds of $1.5M–$4M at Seed and $3M–$20M at Series A. These are whole funding-round sizes, not MEDTEQ+'s own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds MEDTEQ+ took part in.
How do I contact MEDTEQ+?
Public channels for MEDTEQ+ include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at MEDTEQ+?
The team at MEDTEQ+ includes Diane Côté (President & CEO), Jacques Milette (Président sortant du CA, MEDTEQ+) and Meryeme Lahmami (Investment manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
